Human Papilloma Virus 11 E7 (HPV-11 E7) (AA 1-35), (N-Term) antibody
-
- Target
- Human Papilloma Virus 11 E7 (HPV-11 E7)
- Binding Specificity
- AA 1-35, N-Term
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- Un-conjugated
-
Application
- Immunofluorescence (IF), Immunoprecipitation (IP), Western Blotting (WB), Enzyme Immunoassay (EIA)
- Purification
- Affinity chromatography
- Immunogen
- Recombinant full-length HPV-11 E7-protein purified from E. coli
- Clone
- 8G6
- Isotype
- IgG2a
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Concentration
- 1.0 mg/mL
- Buffer
- PBS pH 7.4, with 0.09 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Avoid repeated freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Upon receipt, store (in aliquots) at -20 to -70 °C.
-
- Target
- Human Papilloma Virus 11 E7 (HPV-11 E7)
- Alternative Name
- HPV11 Protein E7
- Target Type
- Viral Protein
- Background
- Human papillomaviruses (HPV) are small DNA viruses which infect epithelia of the skin and mucosa. Over 90 types have been identified and they mostly cause a variety of benign lesions such as warts and verrucae. However, some subtypes, notably types 16 and 18, 31 and 33, have been confirmed as agents which cause cervical cancer. Human Papillomavirus (HPV) E2 proteins are the major viral regulators of transcription and replication during the viral life cycle.Synonyms: Human Papilloma Virus type 11 Early Protein E7
- Gene ID
- 10580
- UniProt
- P04020
-